Cargando…
Engineering hybrid exosomes by membrane fusion with liposomes
Exosomes are a valuable biomaterial for the development of novel nanocarriers as functionally advanced drug delivery systems. To control and modify the performance of exosomal nanocarriers, we developed hybrid exosomes by fusing their membranes with liposomes using the freeze–thaw method. Exosomes e...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766490/ https://www.ncbi.nlm.nih.gov/pubmed/26911358 http://dx.doi.org/10.1038/srep21933 |
_version_ | 1782417676063211520 |
---|---|
author | Sato, Yuko T. Umezaki, Kaori Sawada, Shinichi Mukai, Sada-atsu Sasaki, Yoshihiro Harada, Naozumi Shiku, Hiroshi Akiyoshi, Kazunari |
author_facet | Sato, Yuko T. Umezaki, Kaori Sawada, Shinichi Mukai, Sada-atsu Sasaki, Yoshihiro Harada, Naozumi Shiku, Hiroshi Akiyoshi, Kazunari |
author_sort | Sato, Yuko T. |
collection | PubMed |
description | Exosomes are a valuable biomaterial for the development of novel nanocarriers as functionally advanced drug delivery systems. To control and modify the performance of exosomal nanocarriers, we developed hybrid exosomes by fusing their membranes with liposomes using the freeze–thaw method. Exosomes embedded with a specific membrane protein isolated from genetically modified cells were fused with various liposomes, confirming that membrane engineering methods can be combined with genetic modification techniques. Cellular uptake studies performed using the hybrid exosomes revealed that the interactions between the developed exosomes and cells could be modified by changing the lipid composition or the properties of the exogenous lipids. These results suggest that the membrane-engineering approach reported here offers a new strategy for developing rationally designed exosomes as hybrid nanocarriers for use in advanced drug delivery systems. |
format | Online Article Text |
id | pubmed-4766490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-47664902016-03-02 Engineering hybrid exosomes by membrane fusion with liposomes Sato, Yuko T. Umezaki, Kaori Sawada, Shinichi Mukai, Sada-atsu Sasaki, Yoshihiro Harada, Naozumi Shiku, Hiroshi Akiyoshi, Kazunari Sci Rep Article Exosomes are a valuable biomaterial for the development of novel nanocarriers as functionally advanced drug delivery systems. To control and modify the performance of exosomal nanocarriers, we developed hybrid exosomes by fusing their membranes with liposomes using the freeze–thaw method. Exosomes embedded with a specific membrane protein isolated from genetically modified cells were fused with various liposomes, confirming that membrane engineering methods can be combined with genetic modification techniques. Cellular uptake studies performed using the hybrid exosomes revealed that the interactions between the developed exosomes and cells could be modified by changing the lipid composition or the properties of the exogenous lipids. These results suggest that the membrane-engineering approach reported here offers a new strategy for developing rationally designed exosomes as hybrid nanocarriers for use in advanced drug delivery systems. Nature Publishing Group 2016-02-25 /pmc/articles/PMC4766490/ /pubmed/26911358 http://dx.doi.org/10.1038/srep21933 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Sato, Yuko T. Umezaki, Kaori Sawada, Shinichi Mukai, Sada-atsu Sasaki, Yoshihiro Harada, Naozumi Shiku, Hiroshi Akiyoshi, Kazunari Engineering hybrid exosomes by membrane fusion with liposomes |
title | Engineering hybrid exosomes by membrane fusion with liposomes |
title_full | Engineering hybrid exosomes by membrane fusion with liposomes |
title_fullStr | Engineering hybrid exosomes by membrane fusion with liposomes |
title_full_unstemmed | Engineering hybrid exosomes by membrane fusion with liposomes |
title_short | Engineering hybrid exosomes by membrane fusion with liposomes |
title_sort | engineering hybrid exosomes by membrane fusion with liposomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766490/ https://www.ncbi.nlm.nih.gov/pubmed/26911358 http://dx.doi.org/10.1038/srep21933 |
work_keys_str_mv | AT satoyukot engineeringhybridexosomesbymembranefusionwithliposomes AT umezakikaori engineeringhybridexosomesbymembranefusionwithliposomes AT sawadashinichi engineeringhybridexosomesbymembranefusionwithliposomes AT mukaisadaatsu engineeringhybridexosomesbymembranefusionwithliposomes AT sasakiyoshihiro engineeringhybridexosomesbymembranefusionwithliposomes AT haradanaozumi engineeringhybridexosomesbymembranefusionwithliposomes AT shikuhiroshi engineeringhybridexosomesbymembranefusionwithliposomes AT akiyoshikazunari engineeringhybridexosomesbymembranefusionwithliposomes |